Nutex Health Fined for Misleading Statements in IDR Process

• Lowey Dannenberg P.C. files class action lawsuit against Nutex Health Inc. • Alleges securities violations for investors who purchased Nutex securities between Aug 8, 2024 and Aug 14, 2025 • Claims false and/or misleading statements regarding HaloMD's arbitration results and sustainability of related revenues • Nutex allegedly engaged in a coordinated scheme to defraud insurance companies • Lawsuit filed on behalf of investors who purchased Nutex securities during the Class Period

New York, Sept. 02, 2025 — Lowey Dannenberg P.C., a prominent law firm, has filed a class action lawsuit on behalf of investors who purchased Nutex Health Inc. (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025. The lawsuit alleges that Nutex engaged in securities violations, including false and misleading statements regarding HaloMD's arbitration results and the sustainability of related revenues.

The class action, filed in the U.S. District Court for the Southern District of New York, alleges that Nutex and its partner, HaloMD, engaged in a coordinated scheme to defraud insurance companies by submitting massive volumes of ineligible claims and falsely attesting to their legitimacy. This activity, which funneled lucrative arbitration results to Nutex, was a key driver of the company's reported revenues, which the lawsuit claims were unsustainable and ultimately misleading to investors [2].

The lawsuit also alleges that Nutex overstated the progress it had made in remediating material weaknesses in its internal controls over financial reporting. As a result, the company allegedly improperly accounted for certain stock-based compensation obligations, calculating them as equity rather than liabilities. This accounting issue came to a head when Nutex delayed its financial filing, citing "non-cash accounting adjustments related to the treatment of stock-based compensation obligations" [2].

The class action seeks to recover damages for investors who purchased Nutex securities during the class period, alleging that the defendants' public statements were materially false and misleading, ultimately resulting in significant losses when the alleged truth about the company's business and financial prospects emerged.

Lowey Dannenberg P.C. encourages investors who purchased Nutex securities during the Class Period to contact the firm for more information. The deadline for lead plaintiff selection is October 21, 2025. Investors can join the class action by visiting [www.lowey.com/submit-form/?case_id=43936] or contacting Phillip Kim, Esq. toll-free at 866-767-3653 or emailing case@rosenlegal.com [1].

References:
[1] https://www.globenewswire.com/news-release/2025/09/02/3142990/673/en/ROSEN-A-RANKED-AND-LEADING-LAW-FIRM-Encourages-Nutex-Health-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-NUTX.html
[2] https://www.morningstar.com/news/globe-newswire/9521651/nutex-health-nutx-securities-suit-alleges-fraud-and-financial-misstatements-hagens-berman